News & Perspective

Dec 13, 2012

Dec 13, 2012

With new rules, few public health labs to handle riskiest agents

(CIDRAP News) – With tougher security requirements set to take effect next April, few state public health laboratories plan to maintain stocks of certain pathogens considered most tempting to bioterrorists, according to the Association of Public Health Laboratories (APHL) and officials with state labs.

Oct 10, 2012

Oct 10, 2012

Changes in select agent rules concern public health labs

(CIDRAP News) – The Centers for Disease Control and Prevention (CDC) has revised its list of potentially dangerous biological agents and toxins and the regulations covering them, and some of the changes have public health laboratories concerned.

Aug 17, 2012

Aug 17, 2012

Public health officials respond to critique of BioWatch

In the wake of a newspaper investigation that questioned the value of the federal BioWatch program for detecting dangerous airborne pathogens, some public health officials familiar with the program acknowledge that it's far from perfect, but they say it's not time to scrap it.

Oct 14, 2011

Oct 14, 2011

NIH contracts target broad-spectrum therapies for bioterror threats

(CIDRAP News) – The National Institutes of Health (NIH) yesterday announced it has awarded contracts, which could total $150 million over 5 years, to four companies to develop broad-spectrum therapies that could help the nation respond to a bioterror attack or other public health emergency.

Sep 28, 2011

Sep 28, 2011

Report: 395 mishaps at US labs risked releasing select agents

(CIDRAP News) – US government laboratories had 395 incidents that involved the potential release of select agents between 2003 and 2009, though only seven related infections were reported, according to a new National Research Council (NRC) report.

Pages

Sort Results

 

Narrow results

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»